Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Suppression of kidney fibrosis by cGMP-dependent protein kinase I

  • 735 Accesses

Background

cGMP is synthesized via nitric oxide- or natriuretic peptide-stimulated guanylyl cyclases and exhibits pleiotropic regulatory functions also in the kidney. Both isoforms of cGKI (α, β) have been detected in arterioles, mesangium and within the cortical interstitium. In contrast to cGKIα, the β-isoform was not detected in the juxtaglomerular apparatus and in medullary fibroblasts.

The aim of this study was to examine the function of cGKI in the renal interstitium, emphasizing a functional differentiation of both isoforms. Interstitium fibroblasts play a prominent role in interstitial fibrosis. Accordingly, cGKI may also be involved in this pathophysiological process.

Results

Kidney fibrosis was induced by unilateral ureter obstruction (UUO). We treated αSM-rescue (expressing cGKIα only in smooth muscle under the control of the SM22 promotor with a cGKI-KO background), cGKI-KO mice (expressing no cGKI) and wt mice with YC-1 (sGC stimulator) which increases cGMP concentration.

Administration of YC-1 showed significantly antifibrotic effects in wt-, but not in αSM-rescue- and cGKI-KO mice, especially regarding the fibrosis marker Col1a1, TGFβ and fibronectin. Thereby cGKIα was activated by YC-1 which phosphorylates RhoA and inhibits in turn the profibrotic RhoA/ROCK pathway.

Conclusion

Our results indicate that cGMP/cGKIα acts via RhoA/ROCK, as an important suppressor of kidney fibrosis.

Acknowledgements

This work was supported by grants from the DFG SFB 699.

Author information

Correspondence to Elisabeth Schinner.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Schinner, E., Schramm, A., Kees, F. et al. Suppression of kidney fibrosis by cGMP-dependent protein kinase I. BMC Pharmacol Toxicol 14, P61 (2013). https://doi.org/10.1186/2050-6511-14-S1-P61

Download citation

Keywords

  • Nitric Oxide
  • Protein Kinase
  • Interstitial Fibrosis
  • Functional Differentiation
  • Pathophysiological Process